Genome Map Raises Hope For Vaccine Against Facial Tumour

.

Genome Map Raises Hope For Vaccine Against Facial Tumour

It has been found in a recent report that Tasmania fears the outbreak of devil facial tumour disease (DFTD) in the state, which has already targeted many. As per the report, the disease victimizes only devil populations and is relatively firm.

According to the report findings, a team at the Australian National University had conducted a research, which led them to find out that the fragments of the chromosomes had been jumbled up between the normal Tasmanian devil genome and devil facial tumours.

The team of researchers created a genome map of the facial tumour that led them to conclude that the tumour had a massive number of unusual features. As per their belief, the facial tumour, which is the major cause of deaths in the state, might be killed as the genome map had given them a hope of understanding its origin.

The study has revealed that the tumour had initially emerged in the year 1996 and has been constant and unchanged since then. The team told the reporters that the tumour has been continuously and steadily developing from when it originated years ago. After studying three strains of the tumour, the researchers were able to determine different rearrangements.

However, it has been told by the team that the rearrangements inside different strains were similar that concerned them of the stability of the facial tumour. But, its stability further gave the team a hope of developing a treatment for the same. “The Devil is going to be a good model for looking at some human cancers because it is so stable – with everything happening slower we have a better chance of finding those things out”, said the team. It concluded that the map completed may be helpful in discovering a vaccine against the disease.


Latest News

Toyota Entering Strategic Investment Deal with Uber
HP Enterprise will Spin Off its Enterprise Services Business Merging it with Com
Patrick Soon-Shiong invests $70.5 million in Tribune
Ares Capital planning to acquire American Capital
Although Scientists say GMOs are Safe to Eat But it is Not Easy to Convince Ever
Central States Pension Fund has No New Recovery Plan Seeks Legislation to Protec
Does Fewer Opioid Prescriptions in the U.S Reflect a Curb in the Wave of Addicti
Japan’s Exports Drop further in April adding to a Gloomy Outlook
The Long Drawn Battle for Control Over Sumner Redstone’s Trust Takes New Turn
April Payrolls Reflect Significant Increases in Eleven US States
Bids for Yahoo may Not Match Earlier Expectations